Claim Details

View detailed information about this claim and its related sources.

Claim Information

Complete details about this extracted claim.

Claim Text: Colorado voters went further two years later, passing an initiative that not only authorized "healing centers" but decriminalized the noncommercial production, possession, and transfer of psilocybin and four other naturally occurring psychedelics.
Simplified Text: Colorado decriminalized psilocybin and other psychedelics.
Confidence Score: 0.900
UUID: 55f245de-726d-48d6-9725-bd331ccce23a
Vector Index: ✗ No vector
Created: December 6, 2025 at 12:39 AM (8 months ago)
Last Updated: December 6, 2025 at 12:39 AM (8 months ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication

https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psy...

Completed

18 claims 🔥

1 week ago

https://reason.com/2025/11/12/the-perils-of-viewing-psilocybin-strictly-as-a-psychiatric-medication

Similar Claims (5)

Other claims identified as semantically similar to this one.

Five years ago, Oregon voters took a different approach, approving a ballot initiative that authorized state-licensed "psilocybin service centers" where adults 21 or older can use the drug under the s... 0.900

Simplified: Oregon voters approved psilocybin service centers five years ago.

8 months ago
a Denver ballot initiative in 2019, that discouraged the arrest and prosecution of psychedelic users. 0.900

Simplified: Denver discouraged arresting psychedelic users in 2019.

8 months ago
In a 2023 RAND Corporation survey of people who had used psilocybin in the last year, 49 percent described their goal as "improved mental health," a category that includes but extends beyond individua... 0.800

Simplified: 49% used psilocybin for mental health in a 2023 RAND survey.

8 months ago
In 2018, the FDA recognized psilocybin as a "breakthrough therapy" for "treatment-resistant depression," a designation that was supposed to facilitate regulatory approval. 0.900

Simplified: FDA designated psilocybin a 'breakthrough therapy' in 2018.

8 months ago
The Scottsdale Research Institute (SRI) grows psilocybin mushrooms in Arizona with permission from the Drug Enforcement Administration. 0.900

Simplified: SRI grows psilocybin mushrooms in Arizona with DEA permission.

8 months ago